IOVANCE BIOTHERAPEUTICS, INC. - COM (IOVA)

Historical Portfolio Holders from Q2 2017 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
212 M
Holdings value Q1 2024
$3.14 B
Value change Q1 2024
+$221 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
251
Number of buys Q1 2024
150
Number of sells Q1 2024
-107
Average buys Q1 2024 %
+0.003%
Average sells Q1 2024 %
-0.003%
CUSIP
462260100
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 212 M $3.14 B +$221 M $14.82 251
2023 Q4 203 M $1.65 B -$69.6 M $8.13 233
2023 Q3 212 M $963 M +$6.32 M $4.55 220
2023 Q2 202 M $1.43 B -$6.41 M $7.04 209
2023 Q1 205 M $1.25 B +$199 M $6.11 220
2022 Q4 171 M $1.09 B +$102 M $6.39 205
2022 Q3 147 M $1.41 B -$69.2 M $9.58 220
2022 Q2 153 M $1.69 B +$1.89 M $11.04 220
2022 Q1 154 M $2.57 B +$12.4 M $16.65 227
2021 Q4 149 M $2.83 B -$69 M $19.09 232
2021 Q3 158 M $3.88 B -$128 M $24.66 233
2021 Q2 160 M $4.15 B +$95 M $26.02 228
2021 Q1 156 M $4.93 B +$220 M $31.66 238
2020 Q4 148 M $6.88 B +$444 M $46.40 263
2020 Q3 140 M $4.6 B -$20 M $32.92 240
2020 Q2 141 M $3.87 B +$484 M $27.45 252
2020 Q1 121 M $3.62 B -$46.7 M $29.94 202
2019 Q4 121 M $3.35 B +$5.19 M $27.68 192
2019 Q3 123 M $2.25 B +$1.2 M $18.20 163
2019 Q2 122 M $2.99 B +$222 M $24.52 162
2019 Q1 115 M $1.1 B -$11.2 M $9.51 145
2018 Q4 119 M $1.05 B +$237 M $8.85 135
2018 Q3 88.2 M $992 M +$78.6 M $11.25 127
2018 Q2 80.9 M $1.04 B +$53.1 M $12.80 121
2018 Q1 77.7 M $1.31 B +$340 M $16.90 119
2017 Q4 57.6 M $461 M +$15.9 M $8.00 85
2017 Q3 55.3 M $428 M +$58.6 M $7.75 84
2017 Q2 47.6 M $349 M +$349 M $7.35 79